MoneyWorks4Me

Nectar Lifesciences informs about outcome of board meeting

28 Nov 2020 Evaluate
Nectar Lifesciences has informed that pursuant to Reserve Bank India had vide its circulars permitted one-time restructuring for the accounts which were standard as on march 01, 2020, the Board of Directors in its meeting held on today have decided to opt for the one-time restructuring of its debt and authorised the officers of the company to discuss and/ or finalize the one-time restructuring plan with the banks/ financial institutions and/ or to sign any agreement, document application or paper as is required to accomplish the said one-time restructuring.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..